In 216 patients with non-valvular AF at high risk of ischaemic stroke, the AnchorMan left atrial appendage closure device was non-inferior to Watchman 2.5 for 12-month clinical success (98.1% vs 98.1%); LAA occlusion (secondary) was 100% in both.
RCTn = 216
Wang et al. Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial